Technology Development
Business Development
Revenue
Exited
2011
About
CoreBone is pioneering a first-of-its-kind articular cartilage regeneration platform, addressing orthopedics’ most critical unmet need: true regeneration of articular cartilage and subchondral bone.
Leveraging our proprietary, IP-protected coral cultivation technology, the platform is clinically validated with over 10,000 dental bone grafting procedures. Building on this foundation, the company is developing CoreTlage™, a patented, off-the-shelf bioactive implant designed to regenerate both hyaline-like cartilage and subchondral bone in a single, minimally invasive procedure.
In preclinical studies, CoreTlage™ demonstrated superior regeneration quality compared to existing solutions, restoring hyaline-like cartilage tissue within 6 months, without the need for added cells or multiple surgeries.
Targeting a ~$5B global market with strong strategic acquisition precedents, CoreBone is currently raising capital to initiate its First-in-Human (FIM) clinical study and advance regulatory pathways toward commercialization.
CoreTlage™ - Cartilage Regeneration ProcessMarket Need
The multi-billion-dollar global market for cartilage repair faces a fundamental gap: few solutions can reliably regenerate durable, hyaline-like articular cartilage. Most existing treatments offer only symptom relief or partial repair rather than true tissue regeneration.
Clinical evidence has demonstrated that coral-based biomaterials is the only known material that supports cartilage regeneration, most notably from a FDA-approved third party clinical study. However, CoreBone is the only company that has developed a proprietary, coral growing platform, enabling a controlled, scalable, and sustainable source of medical-grade coral.
This IP protected technology overcomes the limitations of wild-harvested coral, namely variability, supply constraints, and long-term sustainability while ensuring consistent quality and regulatory-grade manufacturing. CoreTlage™, backed by PCT patents for its enhanced stem cell migration technology, is leading the next generation of regenerative solutions for bone and cartilage repair, and beyond.
